The third edition of the NZ Healthtech Report, created in partnership with Medtech-iQ Aotearoa, is an indispensable resource for those who care about innovation in healthcare. In 40 pages, the report quantifies the healthtech sector and its key markets, investment, and business spending. Over 230 companies are collected here, with in-depth profiles on the highest-earning companies and the most exciting start-ups. Based on data from the 2023 TIN Survey, and including expert commentary from key stakeholders, this report shows how healthtech is adjusting to a more stable demand environment post-COVID. Total revenue grew 2.4% in 2023, but over the past decade, New Zealand’s healthtech export sector is shown to have more than doubled, from $1.27B to $2.62B. Find out how innovation and investment today can cure patients and solve problems tomorrow.
Related articles
Start-ups
Virtual reality app oVRcome reduces social anxiety by 35%
A clinical trial has demonstrated that oVRcome, a virtual reality app developed in New Zealand for treating anxiety and phobias, significantly reduces symptoms of social anxiety.
Start-ups
How Med-Tech Startups Can Integrate Compliance Early to Avoid Costly Setbacks
With guidance from the Johner Institute, med-tech startups can navigate complex regulations early and bring innovative products to market safely.
Research
Our Changing World – MRI research at the Mātai Medical Research Institute
The MRI technique advances coming out of the Mātai Medical Research Institute in Gisborne have been described as ‘pioneering’, ‘groundbreaking’ and ‘world leading’. Claire Concannon speaks to chief executive and research director Dr Samantha Holdsworth to learn why, and about their big plans for the future.